News

PEYEONEER Ophthalmic Solutions B.V. has been selected for the Chamber of Commerce Top 100 most innovative companies in the Netherlands! (door: KVK Innovatie Top 100). Now it’s up to the public to decide who will take the crown (Click for the link). Every year, millions of people lose the ability

In July, we’re joined by Christian J.F. Bertens, co-founder and CEO of PEYEONEER Ophthalmic Solutions, a startup developing a novel implant to treat glaucoma, one of the leading causes of blindness worldwide. Christian shares the realities of building a medtech company from the ground up: assembling the right team, navigating

Over €2M subsidy awarded to Medace, PEYEONEER Ophthalmic Solutions, University of Maastricht and the University Eye Clinic Maastricht to develop a new miniature glaucoma implant. Glaucoma, the leading cause of irreversible blindness, currently affects more than 80 million people worldwide and is characterized by permanent vision loss eventually resulting in

Innovative Surgical techniques for Eyes with Advanced glaucoma (I-SEA) Source: Health-Holland.com This innovative project, marked by a strong public-private partnership, aims to revolutionize glaucoma treatment. Glaucoma is a leading cause of irreversible blindness worldwide. Current treatments often have complications, leaving an unmet need for safer and more effective solutions. Through

We are proud to announce that PEYEONEER is now an officially registered trademark. This milestone underscores our commitment to innovation, quality, and trust in everything we do. From now on, whenever you see PEYEONEER®, you can be confident it represents our protected brand and the values we stand for.

In 2023 prof. dr. Henny Beckers and dr. ing. Christian Bertens received a NWO Take-off subsidy to investigate feasibility of a novel glaucoma implant. This subsidy was the foundation of PEYEONEER Ophthalmic Solutions.